Barrio, SantiagoMunawar, UmairZhu, Yuan XiaoGiesen, NicolaShi, Chang-XinDa Viá, MatteoSanchez, RichardBruins, LauraDemler, TheresaMüller, NicoleHaertle, LarissaGaritano, AndoniSteinbrunn, TorstenDanhof, SophiaCuenca, IsabelBarrio-Garcia, ClaraBraggio, EstebanRosenwald, AndreasMartinez-Lopez, JoaquinRasche, LeoRaab, Marc SStewart, A KeithEinsele, HermannStühmer, ThorstenKortüm, K Martin2020-03-252020-03-252019-09-26Haematologica. 2019 pii: haematol.2019.217943.0390-6078http://hdl.handle.net/20.500.12105/9334engVoRhttp://creativecommons.org/licenses/by-nc-sa/4.0/CRL4/CRBN E3 ubiquitin ligaseImmunomodulatory drugsMultiple MyelomaPoint mutationsDrug resistanceIKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myelomaAtribución-NoComercial-CompartirIgual 4.0 Internacional31558666haematol.2019.21794310.3324/haematol.2019.2179431592-8721Haematologicaopen access